TW200306193A - Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use - Google Patents

Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use Download PDF

Info

Publication number
TW200306193A
TW200306193A TW092103808A TW92103808A TW200306193A TW 200306193 A TW200306193 A TW 200306193A TW 092103808 A TW092103808 A TW 092103808A TW 92103808 A TW92103808 A TW 92103808A TW 200306193 A TW200306193 A TW 200306193A
Authority
TW
Taiwan
Prior art keywords
alkyl
group
aryl
integer
compound
Prior art date
Application number
TW092103808A
Other languages
English (en)
Chinese (zh)
Inventor
Robert Steven Kania
William Henry Romines Iii
Stephan James Cripps
Mingying He
Jihong Lou
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of TW200306193A publication Critical patent/TW200306193A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW092103808A 2002-03-01 2003-02-24 Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use TW200306193A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36095202P 2002-03-01 2002-03-01

Publications (1)

Publication Number Publication Date
TW200306193A true TW200306193A (en) 2003-11-16

Family

ID=27789048

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092103808A TW200306193A (en) 2002-03-01 2003-02-24 Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use

Country Status (15)

Country Link
US (1) US6833456B2 (cg-RX-API-DMAC7.html)
EP (1) EP1483268A2 (cg-RX-API-DMAC7.html)
JP (1) JP2005527511A (cg-RX-API-DMAC7.html)
AR (1) AR040398A1 (cg-RX-API-DMAC7.html)
AU (1) AU2003206068A1 (cg-RX-API-DMAC7.html)
BR (1) BR0308162A (cg-RX-API-DMAC7.html)
CA (1) CA2478050A1 (cg-RX-API-DMAC7.html)
GT (1) GT200300046A (cg-RX-API-DMAC7.html)
HN (1) HN2003000080A (cg-RX-API-DMAC7.html)
MX (1) MXPA04008403A (cg-RX-API-DMAC7.html)
PA (1) PA8568101A1 (cg-RX-API-DMAC7.html)
PE (1) PE20030944A1 (cg-RX-API-DMAC7.html)
TW (1) TW200306193A (cg-RX-API-DMAC7.html)
UY (1) UY27685A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003074529A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116082214A (zh) * 2023-02-24 2023-05-09 常州大学 一种2-芳基-3-叔丁基吲哚类化合物、制备方法及其应用

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA77303C2 (en) 2002-06-14 2006-11-15 Pfizer Derivatives of thienopyridines substituted by benzocondensed heteroarylamide useful as therapeutic agents, pharmaceutical compositions and methods for their use
TW200503994A (en) * 2003-01-24 2005-02-01 Novartis Ag Organic compounds
AU2008202205B2 (en) * 2003-12-23 2009-09-10 Pfizer Inc. Novel quinoline derivatives
AP2006003619A0 (en) * 2003-12-23 2006-06-30 Pfizer Novel quinoline derivatives
WO2005066124A1 (ja) * 2003-12-26 2005-07-21 Daiichi Pharmaceutical Co., Ltd. ピロリジン誘導体の製造法
GB0412467D0 (en) * 2004-06-04 2004-07-07 Astrazeneca Ab Chemical compounds
EP1781664B1 (en) 2004-07-30 2013-09-04 MethylGene Inc. Inhibitors of vegf receptor and hgf receptor signaling
MX2007014617A (es) * 2005-05-20 2008-02-11 Methylgene Inc Inhibidores de senalizacion de receptor de factor de crecimiento endotelial bascular y receptor de factor de crecimiento de hepatocitos.
WO2008041053A2 (en) 2005-05-20 2008-04-10 Methylgene, Inc. Inhibitors of vegf receptor and hgf receptor signaling
KR20080027923A (ko) * 2005-08-08 2008-03-28 화이자 인코포레이티드 Vegf-r 억제제의 염 및 다형체
US8003662B2 (en) * 2006-01-30 2011-08-23 Array Biopharma, Inc. Heterobicyclic thiophene compounds and methods of use
WO2007107005A1 (en) * 2006-03-22 2007-09-27 Methylgene, Inc. Inhibitors of protein tyrosine kinase activity
US20110053931A1 (en) * 2006-06-08 2011-03-03 John Gaudino Quinoline compounds and methods of use
MX2010009729A (es) 2008-03-05 2010-12-21 Methylgene Inc Inhibidores de actividad de proteina tirosina quinasa.
KR101126736B1 (ko) * 2008-11-27 2012-04-12 주식회사 레고켐 바이오사이언스 티로신 키나아제 저해 화합물, 이의 이성질체 또는 이의 약학적으로 허용가능한 염 및 이를 포함하는 약학적 조성물
WO2012015324A1 (en) * 2010-07-29 2012-02-02 Bial - Portela & Ca, S.A. Process for the synthesis of substituted urea compounds
US9056877B2 (en) 2011-07-19 2015-06-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US10093660B2 (en) 2013-12-04 2018-10-09 Evotec Internatonal Gmbh Sulfoximine substituted quinazolines for pharmaceutical compositions
SG11201607990QA (en) 2014-04-25 2016-11-29 Pfizer Heteroaromatic compounds and their use as dopamine d1 ligands
CN115746017B (zh) * 2022-11-30 2024-06-07 英维沃化工科技(广州)有限公司 一种噻吩并嘧啶类化合物及其制备方法和应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827305D0 (en) 1988-11-23 1988-12-29 British Bio Technology Compounds
US6177401B1 (en) 1992-11-13 2001-01-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
CA2183655C (en) 1994-02-23 2001-03-06 Lee D. Arnold 4-polycyclic amino-substituted quinazoline derivatives
US5863949A (en) 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
ATE446955T1 (de) 1995-03-30 2009-11-15 Pfizer Prod Inc Chinazolinone derivate
CA2218503C (en) * 1995-04-20 2001-07-24 Pfizer Inc. Arylsulfonyl hydroxamic acid derivatives
CA2223081C (en) 1995-06-07 2001-03-06 Pfizer Inc. Heterocyclic ring-fused pyrimidine derivatives
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
NZ331191A (en) 1996-03-05 2000-03-27 Zeneca Ltd 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof
BR9709959A (pt) 1996-06-24 2000-05-09 Pfizer Derivados tricìclicos de fenilamino substituìdo para o tratamento de doenças hiperproliferativas
BR9709974A (pt) * 1996-06-27 1999-08-10 Pfizer Derivados de 2-(2-oxo-etidileno)-imidazolidin-4-ona e seu uso como inibidores da transferase da proteina de farnesila
HRP970371A2 (en) 1996-07-13 1998-08-31 Kathryn Jane Smith Heterocyclic compounds
AR007855A1 (es) 1996-07-13 1999-11-24 Glaxo Group Ltd Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios, uso en medicinay composiciones farmaceuticas que los contienen
EP0923585B1 (en) 1996-07-18 2002-05-08 Pfizer Inc. Phosphinate based inhibitors of matrix metalloproteases
EP0922030A1 (en) 1996-08-23 1999-06-16 Pfizer Inc. Arylsulfonylamino hydroxamic acid derivatives
IL129825A0 (en) 1996-11-27 2000-02-29 Pfizer Fused bicyclic pyrimidine derivatives
US6077864A (en) 1997-01-06 2000-06-20 Pfizer Inc. Cyclic sulfone derivatives
HUP0000852A2 (hu) 1997-02-03 2001-05-28 Pfizer Products Inc. Aril-szulfonil-amino-hidroxámsav-származékok, valamint e vegyületeket tartalmazó gyógyászati készítmények
JP2000507975A (ja) 1997-02-07 2000-06-27 ファイザー・インク N−ヒドロキシ−β−スルホニルプロピオンアミド誘導体類及びそれらのマトリックスメタロプロテイナーゼ阻害薬としての使用
NZ336836A (en) 1997-02-11 2001-02-23 Pfizer Arylsulfonyl hydroxamic acid derivatives suitable for a broad range of medicinal treatments
CA2291709A1 (en) 1997-05-30 1998-12-03 Merck & Co., Inc. Novel angiogenesis inhibitors
DE69838172T2 (de) 1997-08-22 2008-04-10 Astrazeneca Ab Oxindolylchinazolinderivate als angiogenesehemmer
AU744939B2 (en) 1997-09-26 2002-03-07 Merck & Co., Inc. Novel angiogenesis inhibitors
PA8469501A1 (es) 1998-04-10 2000-09-29 Pfizer Prod Inc Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
PA8469401A1 (es) 1998-04-10 2000-05-24 Pfizer Prod Inc Derivados biciclicos del acido hidroxamico
KR100743287B1 (ko) 1998-05-29 2007-07-26 수젠, 인크. 피롤기로 치환된 2-인돌리논 단백질 인산화 효소 억제제
WO2000038715A2 (en) 1998-12-23 2000-07-06 G.D. Searle & Co. Use of an integrin antagonist and radiation in the treatment of neoplasia
BR0111377A (pt) * 2000-06-06 2003-06-03 Pfizer Prod Inc Derivados de tiofeno úteis como agentes anticancerìgenos
WO2003000194A2 (en) * 2001-06-21 2003-01-03 Pfizer Inc. Thienopyridine and thienopyrimidine anticancer agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116082214A (zh) * 2023-02-24 2023-05-09 常州大学 一种2-芳基-3-叔丁基吲哚类化合物、制备方法及其应用

Also Published As

Publication number Publication date
AR040398A1 (es) 2005-04-06
UY27685A1 (es) 2003-10-31
HN2003000080A (es) 2004-05-05
EP1483268A2 (en) 2004-12-08
PE20030944A1 (es) 2003-11-08
BR0308162A (pt) 2004-12-07
JP2005527511A (ja) 2005-09-15
CA2478050A1 (en) 2003-09-12
GT200300046A (es) 2003-10-10
AU2003206068A1 (en) 2003-09-16
MXPA04008403A (es) 2004-11-26
PA8568101A1 (es) 2003-11-12
US20040019065A1 (en) 2004-01-29
WO2003074529A3 (en) 2003-12-24
WO2003074529A2 (en) 2003-09-12
US6833456B2 (en) 2004-12-21
AU2003206068A8 (en) 2003-09-16

Similar Documents

Publication Publication Date Title
US20250368641A1 (en) Quinoline compounds as inhibitors of kras
JP6035423B2 (ja) 新規な縮合ピリミジン化合物又はその塩
WO2021088945A1 (zh) 作为shp2抑制剂的化合物及其应用
TW202615432A (zh) 稠合三環kras抑制劑
TWI640516B (zh) 作為p97錯合物抑制劑的稠合嘧啶
CN105051047B (zh) 化学个体
WO2020239077A1 (zh) 含氮杂环类衍生物调节剂、其制备方法和应用
WO2019155399A1 (en) Tetrahydroquinazoline derivatives useful as anticancer agents
TW202120496A (zh) 作為cd38抑制劑之雜雙環醯胺
WO2001083456A1 (en) Condensed heteroaryl derivatives
TW200530232A (en) Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligands
US6833456B2 (en) Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use
TW200526639A (en) Pyrazole derivatives and uses thereof
CN107635986A (zh) 取代的喹喔啉衍生物
TW202400601A (zh) 作為parp抑製劑的取代的三環類化合物及其用途
TW201109327A (en) Heterocyclic compound
JP2007504121A (ja) 新たな抗血管形成剤として有用なナフタレン・カルボキサミド及びその誘導体
TW202410891A (zh) 泛素特異性蛋白酶1抑制劑
JP2022511236A (ja) 置換キナゾリノン誘導体、及びmGluR4のポジティブアロステリック調節剤としてのその使用
CN114644627A (zh) AhR抑制剂及其用途
JP2025517026A (ja) Ptpn2阻害剤
TW201127845A (en) Pyrazolothiazole compound
TWI901073B (zh) 噻二唑酮衍生物及其組合物和應用
TW202532070A (zh) 四並環類衍生物抑制劑、其製備方法和應用
WO2023122298A1 (en) Protein stabilizing compounds containing usp28 and/or usp25 targeting ligands